AVITA Medical, Inc. (NASDAQ: RCEL) reported Q1 EPS of ($0.35), $0.06 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $19.3 million versus the consensus estimate of $18.3 million.

GUIDANCE:

AVITA Medical, Inc. sees FY2026 revenue of $80-85 million, versus the consensus of $126.5 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.